Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Cardiovascular and related agents.

¹Department of Organic Chemistry, Semmelweis University, Budapest, Hungary.

|November 1, 2001

Summary

This summary is machine-generated.

Researchers at the Hungarian Institute of Drug Research have identified promising cardiovascular agents. Their work includes novel drug concepts and a compound that has reached the market.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A novel 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanal oxime compound is a potent Transient Receptor Potential Ankyrin 1 and Vanilloid 1 (TRPA1 and V1) receptor antagonist.

Neuroscience·2016

Same author

Multi-aspect candidates for repositioning: data fusion methods using heterogeneous information sources.

Current medicinal chemistry·2012

Same author

Interactions between glycine transporter type 1 (GlyT-1) and some inhibitor molecules - glycine transporter type 1 and its inhibitors (review).

Acta physiologica Hungarica·2012

Same author

α(2)-adrenoceptor agonist-induced inhibition of gastric motor activity is mediated by α(2A)-adrenoceptor subtype in the mouse.

Neurochemistry international·2011

Same author

Pharmacological analysis of alpha(2)-adrenoceptor subtypes mediating analgesic, anti-inflammatory and gastroprotective actions.

Inflammopharmacology·2009

Same author

Semicarbazide-sensitive amine oxidase/vascular adhesion protein 1: recent developments concerning substrates and inhibitors of a promising therapeutic target.

Current medicinal chemistry·2008

Area of Science:

Cardiovascular pharmacology
Medicinal chemistry
Drug discovery

Background:

The Hungarian Institute of Drug Research has a history of developing cardiovascular agents.
Cardiovascular diseases remain a significant global health concern, necessitating continuous drug development.

Purpose of the Study:

To review the research activities and key findings of the Hungarian Institute of Drug Research in the area of cardiovascular agents.
To highlight the discovery of promising drug candidates and novel research concepts.

Main Methods:

Review of published research and internal reports.
Analysis of drug discovery pipelines and development strategies.
Identification of key therapeutic targets in cardiovascular diseases.

Related Experiment Videos

Main Results:

Identification of multiple promising drug candidates for cardiovascular conditions.
One developed compound has successfully reached the market.
Development of innovative concepts and strategies for cardiovascular drug research.

Conclusions:

The Hungarian Institute of Drug Research has made significant contributions to cardiovascular drug discovery.
The institute's research has led to clinically relevant outcomes, including a marketed drug.
Novel research concepts developed by the institute hold potential for future cardiovascular therapeutics.